Bank of America Corporation »

Carmell Therapeutics Corp - US shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-09-30 $249 623 0.40
2024-06-30 $152 115 1.33
2023-12-31 $8 2 4.00

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Amazon (AMZN)

View all positions for Bank of America Corporation

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Virtu Financial
Tower Research Capital
Morgan Stanley

View all funds holding Carmell Therapeutics Corp - US